In this paper, we constructed a novel core–shell structured nanocarrier used as a drug carrier to investigate the storage and controllable release properties of the cancer chemotherapeutic drug etoposide (VP16). The new composite nanocomposite composed of a mesoporous silica shell with magnetic Fe 3 O 4 core and ZnO interlayer with a core–shell structure was prepared by a simple process. The mesoporous nanocarrier possesses high surface area (643.9 m 2 /g), provides large accessible pore volume (0.32 cm 3 /g) for the adsorption of drug molecules, and has a high magnetization saturation value (56.8 emu/g) for drug targeting under foreign magnetic fields, and the ZnO interlayer acts as a good microwave absorber with excellent microwave thermal response property for microwave-triggered drug release (the VP16 release of over 85% under microwave discontinuous irradiation outclasses the 14% within 10 h only stirring release). This multifunctional system shows a good performance for targeting delivery and controllable release of anticancer drugs based on all the properties they possess.
No takes yet. Share an insight, caveat, or question.
Qiu et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: